No Detail Found!

Is Hepatovenocaval Syndrome a Different Entity from Budd-chiari Syndrome in Children?.

Author(s)
Nadia Waheed Department of Pediatric Gastroenterology and Hepatology, The Children Hospital, Lahore, Pakistan
Huma Arshad Cheema Department of Pediatric Gastroenterology and Hepatology, The Children Hospital, Lahore, Pakistan
Hassan Suleman Department of Pediatric Gastroenterology and Hepatology, The Children Hospital, Lahore, Pakistan
Iqra Mushtaq Department of Pediatric Gastroenterology and Hepatology, The Children Hospital, Lahore, Pakistan
Zafar Fayyaz Department of Pediatric Gastroenterology and Hepatology, The Children Hospital, Lahore, Pakistan
Nadeem Anjum Department of Pediatric Gastroenterology and Hepatology, The Children Hospital, Lahore, Pakistan
Abstract
Objective: To differentiate between clinical and demographic spectrum, and outcome in hepatovenocaval syndrome (HVCS) and Budd-Chiari syndrome (BCS). Study Design: Descriptive study. Place and Duration of Study: Division of Pediatric Gastroenterology, Hepatology and Nutrition, The Children Hospital, Lahore, from January 2014 to January 2017. Methodology: All children less than 18 years of age, presenting with ascites and visible veins over abdomen, flanks and back were enrolled in the study. Real time Doppler Ultrasonogram was performed in all children for documentation of intrahepatic part of IVC obstruction along with or without hepatic venous obstruction. Children meeting inclusion criteria underwent liver profile, coagulation profile, diagnostic paracentesis for SAAG gradient, and Gadolinium enhanced multiphasic MR scan. Liver biopsy and venography was performed in selected patients. Results: A total of 92 children presented with ascites, among them 58 children met our inclusion criteria. Intrahepatic IVC obliteration, i.e. HVCS, found in 67% (n=39) and hepatic venous outflow obstruction, i.e. BCS was found in 33% (n=19) children. Children with BCS were older than HVCS with mean age of 9.5 ±2.58 versus 4.12 ±0.977 years. HVCS group had 14 boys and 24 girls with a ratio of 1:1.8, while BCS had a ratio of 1:0.9 with 10 boys and 9 girls. No etiological factor was found for HVCS, while most of patients with BCS had a procoagulant disorder. Caudate lobe hypertrophy was a consistent feature in BCS, while IVC obstruction was found in HVCS persistently. Orthotopic liver transplant was needed in three cases (7.6%) of HVCS and four (20.96%) of BCS cases. Antibiotic therapy has a good role in HVCS, while anticoagulation and diuretics had good result in BCS. Conclusion: Hepatovenocaval syndrome (HVCS) mostly affected younger children, especially girls. BCS usually affected older age groups with pro-coagulant disorders who responded to anticoagulation and diuretic. Further studies are needed to compare both conditions.
Publication Details
Page(s) 344-347
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 5, Year: 2018

Request the full text from PASTIC

References
XueH,LiYC,ShakyaP,PalikheM,JhaRK, 2010.The role of intravascular intervention in the management of Budd-Chiari syndrome,Dig Dis Sci 55 2659 -63
OkudaK,KageM,ShresthaSM, 1998.Proposal of new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion,Hepatology 28 1191 -8
AmarapurkarDN,PunamiyaSJ,PatelND, 2008.Changing spectrum of Budd-Chiari syndrome in India with special reference to nonsurgical treatment,World J Gastroenterol 14 278 -85
KathuriaR,SrivastavaA,YachhaSK,PoddarU,BaijalSS, 2014.Budd-Chiari syndrome in children: clinical features, percutaneous radiological intervention, and outcome,Eur J Gastroenterol Hepatol 269 1030 -8
WangL,ZuMH,GuYM,XuH,ZhangQQ,WeiN, 2013.Budd-Chiari syndrome in children and adolescents: therapeutic radiological intervention Zhonghua,Er Ke Za Zhi 518 590 -4
MancusoA, 2015.Management of Budd-Chiari syndrome in children: same debated issues as in adults,Eur J Gastroenterol Hepatol 27 107 -8
MancusoA, 2014.Budd-chiari syndrome management: Timing of treatment is an open issue,Hepatology 59 1213 -
QiX,HanG,GuoX., 2016.The aetiology of primary Budd-Chiari syndrome - differences between the West and China,Aliment Pharmacol Ther 44 1152 -67
RenW,QiX,YangZ,HanG,FanD, 2013.Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review,Eur J Gastroenterol Hepatol 25 830 -41
BuckleyO,O ' Brien,J , Snow,A , Stunell,H , Lyburn,I , Munk,PL, 2007.Imaging of Budd-Chiari syndrome,Eur Radiol 17 2071 -8
FoxMA,FoxJA,DaviesMH, 2011.Budd-Chiari syndrome - a review of the diagnosis and management,Acute Med 10 5 -9
ShresthaSM,ShresthaS,ShresthaA,TsudaF,EndoK,TakahashiM, 2007.High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal,J Gastroenterol Hepatol 22 1921 -8
ShresthaSM,KageM,LeeBB, 2017.Hepatic vena cava syndrome: New concept of pathogenesis,Hepatol Res 47 603 -15
ShresthaSM,ShresthaS., 2014.Hepatic vena cava syndrome: a common cause of liver cirrhosis in children in Nepal,Trop Gastroenterol 35 85 -95
MukundA,GamanagattiS,AcharyaSK, 2011.Radiological interventions in HVOTO - practical tips,Trop Gastroenterol 32 4 -14
AkamatsuN,SugawaraY,Kokudo N, 2015.Budd-Chiari syndrome and liver transplantation,Intractable Rare Dis Res 4 24 -32
ShuklaA,ParikhH,ModiT,AbrahamP,KambleS,MajumderD, 2015.Hepatic vein obstruction is the most common type of hepatic venous outflow obstruction regardless of socioeconomic status,Ann Gastroenterol 281 130 -4
PaulSB,SreenivasV,GamanagattiSR,SharmaH,DhamijaE, 2015.Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction,Aliment Pharmacol Ther 41 961 -71
0

Citations

0

Downloads

58

Views